Four out of five patients reported improvement or stabilisation of their cancer after 6 months of treatment with ivermectin and mebendazole
The largest real-world human analysis of the use of a combination of ivermectin and mebendazole to treat cancer patients has been conducted.
It reveals that after just 6 months of treatment, 84.4% of cancer patients reported clinical benef